Genetic variants in 5p13.2 and 7q21.1 are associated with treatment for benign prostatic hyperplasia with the α-adrenergic receptor antagonist.
Qian X, Xu D, Liu H, Lin X, Yu Y, Kang J, Sheng X, Xu J, Zheng S, Xu D, et al. Aging Male. 2017 Dec; 20(4):250-256. Epub 2017 Aug 8.